Potassium therapy and gastrointestinal lesions.
D000818:Animals; D002740:Chlorothiazide / Q000009:adverse effects; D004232:Diuretics / Q000009:adverse effects*; D004285:Dogs; D005767:Gastrointestinal Diseases / Q000139:chemically induced*; D000882:Haplorhini; D006801:Humans; D006852:Hydrochlorothiazide / Q000009:adverse effects*; D007421:Intestine, Small; D011188:Potassium / Q000008:administration & dosage; D011189:Potassium Chloride / Q000009:adverse effects*; D014456:Ulcer / Q000139:chemically induced*
D004232:Diuretics; D006852:Hydrochlorothiazide; D011189:Potassium Chloride; D002740:Chlorothiazide; D011188:Potassium